Vitrolife AB (publ) (VTRLY) Stock Price, News & Analysis

Company Overview

Vitrolife AB (publ) is a Sweden‐based life sciences company specializing in products and services for assisted reproduction. The company develops, manufactures and markets a comprehensive portfolio of media and equipment for in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI) and embryo culture. Its product range includes culture media, vitrification solutions for cryopreservation, laboratory instruments such as time‐lapse incubators and micromanipulation tools, as well as consumables designed to support fertility clinics, hospitals and research institutions.

Since its founding in 1994, Vitrolife has expanded its global reach to serve customers in more than 100 countries. The company operates production facilities in Sweden and Denmark and maintains a network of subsidiaries and distribution partners throughout Europe, North America, Asia‐Pacific and Latin America. By combining central manufacturing with regional customer support, Vitrolife aims to ensure product quality, regulatory compliance and responsive technical assistance for its clientele.

Vitrolife’s growth has been underpinned by ongoing investments in research and development. The company collaborates with academic and clinical partners to refine culture systems and incubation technologies, driving improvements in embryo development outcomes. While headquartered in Gothenburg, Sweden, Vitrolife’s international footprint includes sales and support offices in key markets such as the United States and China, reflecting its commitment to address diverse regulatory environments and clinical practices.

Governed by an experienced management team and board of directors, Vitrolife places emphasis on quality management and regulatory standards, adhering to ISO and CE certifications. With a focus on technological innovation and customer service, the company continues to advance solutions that support fertility specialists in optimizing laboratory workflows and achieving higher success rates in assisted reproductive treatments.

Key Stats

• Today's Range: $14.98 to $14.98
• 50-Day Range: $14.90 to $14.98
• 52-Week Range: $14.62 to $17.66
• Volume: N/A
• Average Volume: 133 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VTRLY Stock Analysis - Frequently Asked Questions

How have VTRLY shares performed this year?

Vitrolife AB (publ)'s stock was trading at $18.7470 at the start of the year. Since then, VTRLY shares have decreased by 20.1% and is now trading at $14.98.

How do I buy shares of Vitrolife AB (publ)?

Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/01/2025
• Next Earnings (Estimated): 10/23/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VTRLY
• CIK: N/A
• Web: www.vitrolife.com
• Phone: 46-3-17-21-80-00
• Fax: N/A
• Employees: 1,132
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A